Page 1 | Search Results | Blood | American Society of Hematology

Skip Nav Destination

1-18 of 18

Sort by

Sort Order Select

Journal Articles

Targeting p53 Improves Drug Resistance in Mantle Cell Lymphoma By Regulating Mitophagy-Dependent Ferroptosis

Yingtong Chen, Ping Yang, Weilong Zhang, Jing Wang, Shuang Gao, Yuan Yang, Shuozi Liu, Chunyuan Li, Hongmei Jing

Blood (2024) 144 (Supplement 1): 5836.

https://doi.org/10.1182/blood-2024-205447

Published: 2024

Journal Articles

UHRF1 Is a Promising Therapy Target in Aggressive Mantle Cell Lymphoma

Yuan Yang, Ping Yang, Weilong Zhang, Jing Wang, Yingtong Chen, Chunyuan Li, Hongmei Jing

Blood (2024) 144 (Supplement 1): 5753.

https://doi.org/10.1182/blood-2024-204870

Published: 2024

Journal Articles

Selinexor Synergizes with Decitabine in Mantle Cell Lymphoma through MAPK Signaling Pathway

Yingtong Chen, Ping Yang, Weilong Zhang, Jing Wang, Shuang Gao, Yuan Yang, Shuozi Liu, Chunyuan Li, Hongmei Jing

Blood (2024) 144 (Supplement 1): 5845.

https://doi.org/10.1182/blood-2024-205492

Published: 2024

Journal Articles

Prognostic Significance of POD24 and Monoclonal Paraproteinemia in Extranodal MZL

Lingli Wang, Jinjie Gao, Wei Wan, Fei Dong, Jing Wang, Weilong Zhang, Ping Yang, Lan Ma, Wei Zhao, Jijun Wang, Hongmei Jing

Blood (2024) 144 (Supplement 1): 6340.

https://doi.org/10.1182/blood-2024-205570

Published: 2024

Journal Articles

Phase I Study of a CD19-Directed CAR-T Cell Therapy for Relapsed/Refractory Mantle Cell Lymphomas(MCL)

Ping Yang, Chunyuan Li, Jinjie Gao, Yuan Yang, Shuozi Liu, Jing Wang, Yingtong Chen, Weilong Zhang, Hongmei Jing

Blood (2024) 144 (Supplement 1): 6339.

https://doi.org/10.1182/blood-2024-205068

Published: 2024

Journal Articles

Treatment Outcomes of BTK Inhibitors and Venetoclax with/without Anti-CD20 Monoclonal Antibody in Patients with Relapsed or Refractory Mantle Cell Lymphoma: A Real-World Experience

Ping Yang, Chunyuan Li, Shuozi Liu, Jing Wang, Yingtong Chen, Weilong Zhang, Hongmei Jing

Blood (2024) 144 (Supplement 1): 6338.

https://doi.org/10.1182/blood-2024-205042

Published: 2024

Journal Articles

Central Nervous System Involvement in Mantle Cell Lymphoma: Clinical Features, Prognostic Factors and Outcomes from Multi-Centers in China

Ping Yang, Chunyuan Li, Yuan Yang, Shuozi Liu, Weilong Zhang, Jing Wang, Yingtong Chen, Xiaoyu Hao, Hongmei Jing

Blood (2024) 144 (Supplement 1): 6337.

https://doi.org/10.1182/blood-2024-204938

Published: 2024

Journal Articles

A Comprehensive Stratification Integrated the Clinical, Pathological, and Molecular Biological Features to Distinguish High-Risk Mantle Cell Lymphoma

Ping Yang, Chunyuan Li, Shuozi Liu, Yuan Yang, Weilong Zhang, Jing Wang, Yingtong Chen, Hongmei Jing

Blood (2024) 144 (Supplement 1): 6305.

https://doi.org/10.1182/blood-2024-205002

Published: 2024

Journal Articles

Polatuzumab Vedotin As an Effective Salvage Therapy for Relapsed/Refractory Mantle Cell Lymphoma Resistantance to BTK and BCL Inhibitors

Ping Yang, Chunyuan Li, Yuan Yang, Shuozi Liu, Jing Wang, Yingtong Chen, Weilong Zhang, Hongmei Jing

Blood (2024) 144 (Supplement 1): 6303.

https://doi.org/10.1182/blood-2024-204939

Published: 2024

Journal Articles

TP53 Mutation Heterogeneity Reveals Distinct Prognoses in Mantle Cell Lymphoma

Shuozi Liu, Shaowei Zhou, Weilong Zhang, Jing Wang, Lingli Wang, Chunyuan Li, Yingtong Chen, Wenxin Qi, Ping Yang, Hongmei Jing

Blood (2024) 144 (Supplement 1): 6301.

https://doi.org/10.1182/blood-2024-204877

Published: 2024

Journal Articles

The Efficacy of Obinutuzumab Combined with Pomalidomide and Covalent Btki for the Treatment of TP53 Mutated Mantle Cell Lymphoma (MCL): A Prospective, Open-Label, Single-Arm Study

Ping Yang, Shuozi Liu, Weilong Zhang, Jing Wang, Yingtong Chen, Hongmei Jing

Blood (2023) 142 (Supplement 1): 3049.

https://doi.org/10.1182/blood-2023-184372

Published: 2023

Journal Articles

Phase I Study of a CD19-Directed CAR-T Cell Therapy for Relapsed/Refractory Mantle Cell Lymphomas(MCL)

Ping Yang, Shuozi Liu, Weilong Zhang, Jing Wang, Hongmei Jing

Blood (2023) 142 (Supplement 1): 4423.

https://doi.org/10.1182/blood-2023-184348

Published: 2023

Journal Articles

Evaluating Chatgpt As an Adjunct for Analyzing Challenging Case

Xiaoni Liu, Ying Song, Hai Lin, Yiying Xu, Chao Chen, Changjian Yan, Xiaoliang Yuan, Fang Bao, Hongmei Jing, Chaoling Wu, Weilong Zhang

Blood (2023) 142 (Supplement 1): 7273.

https://doi.org/10.1182/blood-2023-181518

Published: 2023

Journal Articles

Genomic Landscape and Distinct Molecular Subsets of Primary Testicular Lymphoma

Weilong Zhang, Ping Yang, Yaru Yang, Yongdeng Xu, Jing Wang, Cuiling Liu, Hui Liu, Hongmei Jing

Blood (2022) 140 (Supplement 1): 11910.

https://doi.org/10.1182/blood-2022-165594

Published: 2022

Journal Articles

Genetic and Prognostic Analysis in Blastoid and Pleomorphic Mantle Cell Lymphoma: A Multicenter Analysis in China

Ping Yang, Shuozi Liu, Chunyuan Li, Weilong Zhang, Jing Wang, Yingtong Chen, Sen Li, Cuiling Liu, Hui Liu, Qingqing Cai, Wei Zhang, Hongmei Jing

Blood (2022) 140 (Supplement 1): 11907–11908.

https://doi.org/10.1182/blood-2022-165107

Published: 2022

Journal Articles

Single-Cell Immune Landscape of Measurable Residual Disease in AML after Allogeneic Hematopoietic Stem Cell Transplantation

Xiao-Dong Mo, Weilong Zhang, Guomei Fu, Ying-Jun Chang, Xiao-hui Zhang, Lanping Xu, Yu Wang, Chen-Hua Yan, Meng-Zhu Shen, Qiu-Xia Wei, Changjian Yan, Xiao-jun Huang

Blood (2022) 140 (Supplement 1): 12908–12909.

https://doi.org/10.1182/blood-2022-165909

Published: 2022

Journal Articles

Clinical and Molecular Biology Analysis of Patients with Mantle Cell Lymphoma Resistant to BTK Inhibitor

Lingli Wang, Ping Yang, Weilong Zhang, Jing Wang, Hongmei Jing

Blood (2021) 138 (Supplement 1): 4527.

https://doi.org/10.1182/blood-2021-149114

Published: 2021

Journal Articles

Next-Generation Sequencing Reveals Molecular Heterogeneity in Primary Testicular DLBCL

Shuozi Liu, Ping Yang, Jing Wang, Weilong Zhang, Hongmei Jing

Blood (2021) 138 (Supplement 1): 1426.

https://doi.org/10.1182/blood-2021-149039

Published: 2021

NARROW

Targeting p53 Improves Drug Resistance in Mantle Cell Lymphoma By Regulating Mitophagy-Dependent Ferroptosis

UHRF1 Is a Promising Therapy Target in Aggressive Mantle Cell Lymphoma

Selinexor Synergizes with Decitabine in Mantle Cell Lymphoma through MAPK Signaling Pathway

Prognostic Significance of POD24 and Monoclonal Paraproteinemia in Extranodal MZL

Phase I Study of a CD19-Directed CAR-T Cell Therapy for Relapsed/Refractory Mantle Cell Lymphomas(MCL)

Treatment Outcomes of BTK Inhibitors and Venetoclax with/without Anti-CD20 Monoclonal Antibody in Patients with Relapsed or Refractory Mantle Cell Lymphoma: A Real-World Experience

Central Nervous System Involvement in Mantle Cell Lymphoma: Clinical Features, Prognostic Factors and Outcomes from Multi-Centers in China

A Comprehensive Stratification Integrated the Clinical, Pathological, and Molecular Biological Features to Distinguish High-Risk Mantle Cell Lymphoma

Polatuzumab Vedotin As an Effective Salvage Therapy for Relapsed/Refractory Mantle Cell Lymphoma Resistantance to BTK and BCL Inhibitors

TP53 Mutation Heterogeneity Reveals Distinct Prognoses in Mantle Cell Lymphoma

The Efficacy of Obinutuzumab Combined with Pomalidomide and Covalent Btki for the Treatment of TP53 Mutated Mantle Cell Lymphoma (MCL): A Prospective, Open-Label, Single-Arm Study

Phase I Study of a CD19-Directed CAR-T Cell Therapy for Relapsed/Refractory Mantle Cell Lymphomas(MCL)

Evaluating Chatgpt As an Adjunct for Analyzing Challenging Case

Genomic Landscape and Distinct Molecular Subsets of Primary Testicular Lymphoma

Genetic and Prognostic Analysis in Blastoid and Pleomorphic Mantle Cell Lymphoma: A Multicenter Analysis in China

Single-Cell Immune Landscape of Measurable Residual Disease in AML after Allogeneic Hematopoietic Stem Cell Transplantation

Clinical and Molecular Biology Analysis of Patients with Mantle Cell Lymphoma Resistant to BTK Inhibitor

Next-Generation Sequencing Reveals Molecular Heterogeneity in Primary Testicular DLBCL

Email alerts

ASH Publications

American Society of Hematology

Email alerts

ASH Publications

American Society of Hematology

This Feature Is Available To Subscribers Only